... passer directement � l'angioplastie
Surtout pas tous le temps et pour tout le monde n'importe o�

Des meilleures nouvelles :

Early Revascularization After Thrombolysis Safe After STEMI

NEW YORK (Reuters Health) Sept 16 - In patients with ST-segment
elevated myocardial infarction (STEMI), early thrombolysis followed
shortly thereafter by cardiac catheterization with myocardial
revascularization and stent implantation leads to better outcomes
than a more conservative approach, physicians in Spain report.

Thrombolysis alone is associated with a high rate of failed
reperfusion and reocclusion, Dr. Francisco Fernandez-Aviles and
colleagues explain in the September 18th issue of The Lancet. Before
the current "era of stents and new antiplatelet agents," routine
angioplasty soon after thrombolysis was associated with increased
risk of complications in STEMI patients.

More recently, studies show that stent implantation soon after
thrombolysis is safe and prevents reocclusion. Dr. Fernandez-Aviles'
group therefore designed the GRACIA-1 trial to evaluate the benefits
of an early post-thrombolysis interventional strategy.

Five hundred patients with STEMI underwent intravenous thrombolysis
with fibrin-specific agents. They were then randomized to coronary
angiography and revascularization, if indicated, within 24 hours 
(n = 248), or an ischemia-guided conservative tactic, in which
revascularization was performed only in cases with spontaneous or
stress-induced ischemia (n = 252).

In the active intervention group, 199 patients underwent stenting of
the culprit artery, 51 had non-culprit artery stenting, 6 had
coronary bypass surgery, and 41 underwent medical treatment only. 
In the watchful waiting group, 51 patients required predischarge
ischemia-driven revascularization with stenting.

Major bleeding rates were 1.6% in each group. By the 30-day mark,
2.4% in each treatment arm had died, while three in the invasive
group and four in the conservative group had reinfarction.

However, the average index hospital duration was significantly
shorter in the invasive group, 7.1 days versus 10.5 days (p = 0.001).

After 1 year, the primary combined endpoint of death, nonfatal
reinfarction or revascularization was reached by significantly more
in the conservative treatment group (21% versus 9%, p = 0.0008).

In contrast to balloon angioplasty, stent implantation impedes
subintimal hemorrhage and reduces rethrombosis, Dr. Fernandez-Aviles
and his associates suggest, which probably explains the outcomes of
the GRACIA-1 trial.

"Altogether, these findings should affect clinical practice," they
conclude.
"The strategy of stenting hours after intravenous thrombolysis is
applicable to the entire population with acute myocardial
infarction."

In a related editorial, Dr. Freek W. A. Verheugt, at University
Medical Centre in Nijmegen, Netherlands, writes, "The concept of
fibrinolysis first and then angioplasty is attractive: Early
reperfusion by a widely available strategy to salvage as much
myocardium as possible followed by a definitive treatment,
angioplasty with stenting, to ensure both reperfusion in case of
lytic failure and prevention of reocclusion and reinfarction."

Lancet 2004;364:1014-1015, 1045-1053.

--- URG-L
Si vous avez plusieurs adresses email, vous pouvez les envoyer a 
Frederic Giroux a l'adresse [EMAIL PROTECTED]  Un (ou des) alias 
pourront ainsi etre crees pour que vous puissiez envoyer des messages 
a travers la liste a partir de n'importe quel de vos alias.  
Autrement, les messages qui proviennent d'une adresse non-listee sont 
automatiquement rejetes.

Répondre à